Industry / Albania
Pharmaceuticals in South East Europe and the CIS
May 2006 | Special ReportThe emerging pharmaceuticals markets of South East Europe and the CIS represented a combined value of US$1.7bn in 2004, and BMI expects value to reach US$2.1bn in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
